vidarabine has been researched along with Nephrotic Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haller, NA; Lee, B; Novak, R; Robertson, S; Smith, RS; Tanphaichitr, N | 1 |
| Horie, T; Horikoshi, A; Hosokawa, Y; Sawada, S; Takei, K | 1 |
| Austin, H; Balow, JE; Barrett, J; Childs, R; Geller, N; Igarashi, T; Lundqvist, A; Sabnis, S; Srinivasan, R; Takahashi, Y; Tisdale, J | 1 |
| Abdel-Raheem, MM; Gross, GG; Jamil, MG; Potti, A | 1 |
4 other study(ies) available for vidarabine and Nephrotic Syndrome
| Article | Year |
|---|---|
Waldenström's macroglobulinemia and nephrotic syndrome with membranous nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Glomerulonephritis, Membranous; Humans; Immunoglobulin lambda-Chains; Immunoglobulin M; Male; Nephrotic Syndrome; Rituximab; Vidarabine; Waldenstrom Macroglobulinemia | 2011 |
[Successful treatment with fludarabine of chronic lymphocytic leukemia associated with nephrotic syndrome].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Nephrotic Syndrome; Vidarabine | 2002 |
Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclophosphamide; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2005 |
Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.
Topics: Antineoplastic Agents; Diagnosis, Differential; Female; Glomerulonephritis, Membranous; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Nephrotic Syndrome; Proteinuria; Remission Induction; Treatment Outcome; Vidarabine | 2000 |